This 1 Sub-$20 Stock Could Beat Tesla?
Learn about the AV tech company that’s quietly raising BILLIONS in Tesla’s shadow… while its stock still trades for under $20 a share.
Get Details HERE.

CYCC Insider Trading (Cyclacel Pharmaceuticals)

Insider Ownership Percentage: 1.08%
Insider Buying (Last 12 Months): $18,000.00
Insider Selling (Last 12 Months): $42.84

Cyclacel Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Cyclacel Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cyclacel Pharmaceuticals Share Price & Price History

Current Price: $3.62
Price Change: Price Decrease of -0.03 (-0.82%)
As of 01/14/2022 01:00 AM ET

This chart shows the closing price history over time for CYCC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!

Cyclacel Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2021Sam L BarkerDirectorSell12$3.57$42.84View SEC Filing Icon  
11/18/2021Spiro George RombotisCEOBuy4,000$4.50$18,000.00View SEC Filing Icon  
See Full Table
Insider Selling at Cyclacel Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cyclacel Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)

37.00% of Cyclacel Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CYCC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cyclacel Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Two Sigma Advisers LP121,500$0.64M0.0%+929.7%1.316%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP30,221$0.16M0.0%-35.8%0.327%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC105,141$0.55M0.0%-33.2%1.139%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley112,221$0.59M0.0%-7.5%1.215%Search for SEC Filing on Google Icon
11/15/2021Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP13,963$74K0.0%N/A0.151%Search for SEC Filing on Google Icon
11/12/2021Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC58,934$0.31M0.0%+15.9%0.638%Search for SEC Filing on Google Icon
11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108%Search for SEC Filing on Google Icon
10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley121,275$0.72M0.0%+21.3%1.313%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC100,000$0.59M0.0%-66.7%1.083%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716%Search for SEC Filing on Google Icon
8/16/2021Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley121,275$0.72M0.0%+21.3%1.313%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC102,525$0.61M0.0%-25.0%1.110%Search for SEC Filing on Google Icon
8/16/2021Maven Securities LTD234,500$1.43M0.1%-6.2%2.540%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp14,957$89K0.0%N/A0.162%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC50,860$0.30M0.0%+143.3%0.551%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548%Search for SEC Filing on Google Icon
7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC13,108$93K0.0%+27.3%0.142%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC23,836$0.17M0.0%N/A0.258%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC116,674$0.83M0.0%N/A1.264%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley100,000$0.71M0.0%-13.0%1.083%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC293,867$2.09M0.0%N/A3.182%Search for SEC Filing on Google Icon
5/18/2021Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC136,725$0.97M0.0%N/A1.481%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC20,904$0.15M0.0%N/A0.226%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC273,958$1.95M0.1%-42.3%2.967%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC34,057$0.24M0.0%N/A0.369%Search for SEC Filing on Google Icon
4/12/2021Valeo Financial Advisors LLC4,500$32K0.0%N/A0.063%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC10,293$80K0.0%N/A0.212%Search for SEC Filing on Google Icon
2/16/2021Pura Vida Investments LLC475,000$3.71M0.1%N/A9.766%Search for SEC Filing on Google Icon
2/16/2021Acuta Capital Partners LLC150,000$1.17M0.3%N/A3.084%Search for SEC Filing on Google Icon
2/12/2021Raymond James Financial Services Advisors Inc.57,006$0.45M0.0%+24.6%1.172%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC391,450$3.06M0.1%N/A8.048%Search for SEC Filing on Google Icon
11/4/2020Raymond James Financial Services Advisors Inc.45,756$0.17M0.0%+48.8%0.941%Search for SEC Filing on Google Icon
7/17/2020Raymond James Financial Services Advisors Inc.30,756$0.14M0.0%-48.8%0.633%Search for SEC Filing on Google Icon
7/16/2020Wedbush Securities Inc.29,300$0.14M0.0%N/A0.603%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC1,269,326$0.85M0.0%+8.4%7.380%Search for SEC Filing on Google Icon
2/12/2020Raymond James Financial Services Advisors Inc.60,125$40K0.0%-20.0%0.350%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC50,232$34K0.0%+90.3%0.292%Search for SEC Filing on Google Icon
8/12/2019Renaissance Technologies LLC1,102,400$0.60M0.0%+82.5%6.409%Search for SEC Filing on Google Icon
8/13/2018Renaissance Technologies LLC91,400$0.13M0.0%+513.4%0.762%Search for SEC Filing on Google Icon
2/14/2018Two Sigma Investments LP70,310$0.12M0.0%N/A0.591%Search for SEC Filing on Google Icon
2/9/2018Citadel Advisors LLC61,900$0.11M0.0%N/A0.520%Search for SEC Filing on Google Icon
2/9/2018Virtu Financial LLC199,464$0.35M0.0%+69.5%1.676%Search for SEC Filing on Google Icon
8/14/2017Tang Capital Management LLC559,900$2.11M0.7%No Change0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Read More on Cyclacel Pharmaceuticals

Today's Range

Now: $3.62
Low: $3.50
High: $3.65

50 Day Range

MA: $3.89
Low: $3.24
High: $5.10

52 Week Range

Now: $3.62
Low: $3.15
High: $11.42

Volume

52,482 shs

Average Volume

96,060 shs

Market Capitalization

$36.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals' top insider investors include:
  1. Sam L Barker (Director)
  2. Spiro George Rombotis (CEO)
3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.